Literature DB >> 1352862

Autoradiographic localization of receptors for glucagon-like peptide-1 (7-36) amide in rat brain.

L O Uttenthal1, A Toledano, E Blázquez.   

Abstract

Glucagon-like peptide-1 (GLP-1) has a sparse but well defined distribution in the rat brain where it is co-localized with glucagon-like immunoreactivity due to other fragments of the glucagon precursor. We have investigated the localization of GLP-1 receptors in rat brain using mono-125I-iodinated GLP-1(7-36) amide, the biologically active form of the peptide that occurs in brain, as the tracer for binding and autoradiographic studies of tissue sections. Displaceable binding of the label was sharply localized to discrete areas, being high in mamillary nuclei, the arcuate nucleus, nucleus of the solitary tract and the pretectal area, intermediate in the lateral septal nuclei, olfactory bulb, dorsal tegmental nuclei and the interpenduncular nucleus, and low in other regions. These results indicate areas where GLP-1(7-36) amide may have a role as a neurotransmitter or neuromodulator.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1352862     DOI: 10.1016/0143-4179(92)90036-v

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  10 in total

1.  Circulating GLP-1 and CCK-8 reduce food intake by capsaicin-insensitive, nonvagal mechanisms.

Authors:  Jingchuan Zhang; Robert C Ritter
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-10-26       Impact factor: 3.619

2.  The inhibitory effect of glucagon-like peptide-1 (GLP-1) 7-36 amide on gastric acid secretion in humans depends on an intact vagal innervation.

Authors:  A Wettergren; M Wøjdemann; S Meisner; F Stadil; J J Holst
Journal:  Gut       Date:  1997-05       Impact factor: 23.059

Review 3.  The effect of glucagon-like peptide 1 on cardiovascular risk.

Authors:  Jacob Sivertsen; Jaya Rosenmeier; Jens J Holst; Tina Vilsbøll
Journal:  Nat Rev Cardiol       Date:  2012-01-31       Impact factor: 32.419

Review 4.  Glucagon-like peptide-1 (7-36) amide as a novel neuropeptide.

Authors:  E Blázquez; E Alvarez; M Navarro; I Roncero; F Rodríguez-Fonseca; J A Chowen; J A Zueco
Journal:  Mol Neurobiol       Date:  1998-10       Impact factor: 5.590

Review 5.  Visceral sensory inputs to the endocrine hypothalamus.

Authors:  Linda Rinaman
Journal:  Front Neuroendocrinol       Date:  2007-02-22       Impact factor: 8.606

6.  Vagally mediated effects of glucagon-like peptide 1: in vitro and in vivo gastric actions.

Authors:  Gregory M Holmes; Kirsteen N Browning; Melissa Tong; Emily Qualls-Creekmore; R Alberto Travagli
Journal:  J Physiol       Date:  2009-08-12       Impact factor: 5.182

7.  Fluid intake, what's dopamine got to do with it?

Authors:  Elizabeth G Mietlicki-Baase; Jessica Santollo; Derek Daniels
Journal:  Physiol Behav       Date:  2021-04-07

8.  Additive feeding inhibitory and aversive effects of naltrexone and exendin-4 combinations.

Authors:  N-C Liang; N T Bello; T H Moran
Journal:  Int J Obes (Lond)       Date:  2012-02-07       Impact factor: 5.095

9.  Brain glucagon-like peptide-1 regulates arterial blood flow, heart rate, and insulin sensitivity.

Authors:  Cendrine Cabou; Gérard Campistron; Nicolas Marsollier; Corinne Leloup; Celine Cruciani-Guglielmacci; Luc Pénicaud; Daniel J Drucker; Christophe Magnan; Rémy Burcelin
Journal:  Diabetes       Date:  2008-07-15       Impact factor: 9.461

Review 10.  Glucagon-Like Peptide-1 (GLP-1) in the Integration of Neural and Endocrine Responses to Stress.

Authors:  Yolanda Diz-Chaves; Salvador Herrera-Pérez; Lucas C González-Matías; José Antonio Lamas; Federico Mallo
Journal:  Nutrients       Date:  2020-10-28       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.